The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition

Journal of Biological Chemistry

Volumn 288, Issue 38, 2013, Pages 27680-27691

  Tang, Ming ^a   Shen, Huangxuan ^a,b   Jin, Yue ^a   Lin, Tong ^a   Cai, Qingsong ^a   Pinard, Melissa A ^a   Biswas, Shyamasri ^a   Tran, Quyen ^c   Li, Guangyao ^a   Shenoy, Anitha K ^a   Tongdee, Emily ^a   Lin, Shuibin ^a   Gu, Yumei ^a   Law, Brian K ^a   Zhou, Lei ^a   McKenna, Robert ^a   Wu, Lizi ^a   Lu, Jianrong ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c AGNES SCOTT COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL PURIFICATION; CHROMATIN MODIFICATION; DOMAIN-CONTAINING PROTEINS; EPIGENETIC REGULATION; EPITHELIAL CELLS; HISTONE MODIFICATION; NOVEL COMPONENT; TRANSCRIPTIONAL REPRESSION;

AMINO ACIDS; CHEMICAL REACTIONS; DISEASES; GENES; MAMMALS; NICKEL; TRANSCRIPTION;

PROTEINS;

HISTONE DEMETHYLASE; HISTONE H3; HISTONE H3 LYSINE 4; LYSINE SPECIFIC DEMETHYLASE 1; NERVE CELL ADHESION MOLECULE; NICKEL; REGULATOR PROTEIN; SCM LIKE WITH FOUR MALIGNANT BRAIN TUMOR DOMAINS 1 PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; GENE REPRESSION; HISTONE DEMETHYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RECURRENCE FREE SURVIVAL;

CELL INVASION; CHROMATIN HISTONE MODIFICATION; EPIGENETICS; EPITHELIAL-TO-MESENCHYMAL TRANSITION; NICKEL; TRANSCRIPTION REPRESSOR;

CARCINOGENS; CHROMATIN; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HEK293 CELLS; HISTONE DEMETHYLASES; HISTONES; HUMANS; METHYLATION; NEOPLASM PROTEINS; NEOPLASMS; NICKEL; REPRESSOR PROTEINS; TRACE ELEMENTS; TRANSCRIPTION FACTORS;

EID: 84884584249     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.482349     Document Type: Article

References (56)

1. Kouzarides, T. (2007) Chromatin modifications and their function. Cell 128, 693-705
2. Li, B., Carey, M., and Workman, J. L. (2007) The role of chromatin during transcription. Cell 128, 707-719
3. Berger, S. L. (2007) The complex language of chromatin regulation during transcription. Nature 447, 407-412
4. Campos, E. I., and Reinberg, D. (2009) Histones. Annotating chromatin. Annu. Rev. Genet. 43, 559-599
5. Taverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D., and Patel, D. J. (2007) How chromatin-binding modules interpret histone modifications. Lessons from professional pocket pickers. Nat. Struct. Mol. Biol. 14, 1025-1040
6. Musselman, C. A., Lalonde, M. E., Côté, J., and Kutateladze, T. G. (2012) Perceiving the epigenetic landscape through histone readers. Nat. Struct. Mol. Biol. 19, 1218-1227
7. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., and Shi, Y. (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953
8. Adamo, A., Sesé, B., Boue, S., Castaño, J., Paramonov, I., Barrero, M. J., and Izpisua Belmonte, J. C. (2011) LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells. Nat. Cell Biol. 13, 652-659
9. Whyte, W. A., Bilodeau, S., Orlando, D. A., Hoke, H. A., Frampton, G. M., Foster, C. T., Cowley, S. M., and Young, R. A. (2012) Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 482, 221-225
10. Sun, G., Alzayady, K., Stewart, R., Ye, P., Yang, S., Li, W., and Shi, Y. (2010) Histone demethylase LSD1 regulates neural stem cell proliferation. Mol. Cell. Biol. 30, 1997-2005
11. Wang, J., Scully, K., Zhu, X., Cai, L., Zhang, J., Prefontaine, G. G., Krones, A., Ohgi, K. A., Zhu, P., Garcia-Bassets, I., Liu, F., Taylor, H., Lozach, J., Jayes, F. L., Korach, K. S., Glass, C. K., Fu, X. D., and Rosenfeld, M. G. (2007) Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446, 882-887
12. Saleque, S., Kim, J., Rooke, H. M., and Orkin, S. H. (2007) Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol. Cell 27, 562-572
13. Hu, X., Li, X., Valverde, K., Fu, X., Noguchi, C., Qiu, Y., and Huang, S. (2009) LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc. Natl. Acad. Sci. U. S. A. 106, 10141-10146
14. Su, S. T., Ying, H.-Y., Chiu, Y.-K., Lin, F.-R., Chen, M.-Y., and Lin, K.-I. (2009) Involvement of histone demethylase LSD1 in Blimp-1-mediated gene repression during plasma cell differentiation. Mol. Cell. Biol. 29, 1421-1431
15. Xu, J., Bauer, D. E., Kerenyi, M. A., Vo, T. D., Hou, S., Hsu, Y. J., Yao, H., Trowbridge, J. J., Mandel, G., and Orkin, S. H. (2013) Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. Proc. Natl. Acad. Sci. U. S. A. 110, 6518-6523
16. Cui, S., Kolodziej, K. E., Obara, N., Amaral-Psarris, A., Demmers, J., Shi, L., Engel, J. D., Grosveld, F., Strouboulis, J., and Tanabe, O. (2011) Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic α-type globin promoters in differentiated adult erythroid cells. Mol. Cell. Biol. 31, 3298-3311
17. Huang, J., Sengupta, R., Espejo, A. B., Lee, M. G., Dorsey, J. A., Richter, M., Opravil, S., Shiekhattar, R., Bedford, M. T., Jenuwein, T., and Berger, S. L. (2007) p53 is regulated by the lysine demethylase LSD1. Nature 449, 105-108
18. Tsai, W. W., Nguyen, T. T., Shi, Y., and Barton, M. C. (2008) p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo. Mol. Cell. Biol. 28, 5139-5146
19. Mulligan, P., Yang, F., Di Stefano, L., Ji, J.-Y., Ouyang, J., Nishikawa, J. L., Toiber, D., Kulkarni, M., Wang, Q., Najafi-Shoushtari, S. H., Mostoslavsky, R., Gygi, S. P., Gill, G., Dyson, N. J., and Näär, A. M. (2011) A SIRT1-LSD1 corepressor complex regulates Notch target gene expression and development. Mol. Cell 42, 689-699
20. Yatim, A., Benne, C., Sobhian, B., Laurent-Chabalier, S., Deas, O., Judde, J. G., Lelievre, J. D., Levy, Y., and Benkirane, M. (2012) NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol. Cell 48, 445-458
21. Lin, Y., Wu, Y., Li, J., Dong, C., Ye, X., Chi, Y. I., Evers, B. M., and Zhou, B. P. (2010) The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1. EMBO J. 29, 1803-1816
22. Lin, T., Ponn, A., Hu, X., Law, B. K., and Lu, J. (2010) Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 29, 4896-4904
23. Wu, Z. Q., Li, X. Y., Hu, C. Y., Ford, M., Kleer, C. G., and Weiss, S. J. (2012) Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic breast cancer 1, early onset (BRCA1) repression. Proc. Natl. Acad. Sci. U. S. A. 109, 16654-16659
24. Peinado, H., Olmeda, D., and Cano, A. (2007) Snail, Zeb, andbHLHfactors in tumor progression. An alliance against the epithelial phenotype? Nat. Rev. Cancer 7, 415-428
25. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009) Epithelialmesenchymal transitions in development and disease. Cell 139, 871-890
26. Kahl, P., Gullotti, L., Heukamp, L. C., Wolf, S., Friedrichs, N., Vorreuther, R., Solleder, G., Bastian, P. J., Ellinger, J., Metzger, E., Schüle, R., and Buettner, R. (2006) Androgen receptor coactivators lysinespecific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res. 66, 11341-11347
27. Schulte, J. H., Lim, S., Schramm, A., Friedrichs, N., Koster, J., Versteeg, R., Ora, I., Pajtler, K., Klein-Hitpass, L., Kuhfittig-Kulle, S., Metzger, E., Schüle, R., Eggert, A., Buettner, R., and Kirfel, J. (2009) Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma. Implications for therapy. Cancer Res. 69, 2065-2071
28. Lim, S., Janzer, A., Becker, A., Zimmer, A., Schüle, R., Buettner, R., and Kirfel, J. (2010) Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31, 512-520
29. Serce, N., Gnatzy, A., Steiner, S., Lorenzen, H., Kirfel, J., and Buettner, R. (2012) Elevated expression of LSD1 (lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast. BMC Clin. Pathol. 12, 13
30. Jie, D., Zhongmin, Z., Guoqing, L., Sheng, L., Yi, Z., Jing, W., and Liang, Z. (2013) Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer. Dig. Dis. Sci. 58, 1581-1589
31. Lee, M. G., Wynder, C., Cooch, N., and Shiekhattar, R. (2005) An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437, 432-435
32. Shi, Y.-J., Matson, C., Lan, F., Iwase, S., Baba, T., and Shi, Y. (2005) Regulation of LSD1 histone demethylase activity by its associated factors. Mol. Cell 19, 857-864
33. Yang, M., Gocke, C. B., Luo, X., Borek, D., Tomchick, D. R., Machius, M., Otwinowski, Z., and Yu, H. (2006) Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase. Mol. Cell 23, 377-387
34. Wu, S., Trievel, R. C., and Rice, J. C. (2007) Human SFMBT is a transcriptional repressor protein that selectively binds the N-terminal tail of histone H3. FEBS Lett. 581, 3289-3296
35. Bonasio, R., Lecona, E., and Reinberg, D. (2010) MBT domain proteins in development and disease. Semin. Cell Dev. Biol. 21, 221-230
36. Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D. M., and Nakatani, Y. (2002) A complex with chromatin modifiers that occupies E2F-and Mycresponsive genes in G0 cells. Science 296, 1132-1136
37. Lee, S. H., Lee, S.-J., Jung, Y. S., Xu, Y., Kang, H. S., Ha, N.-C., and Park, B.-J. (2009) Blocking of p53-Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function. Neoplasia 11, 22-31
38. Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., and Hung, M.-C. (2004) Dual regulation of Snail by GSK-3α-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6, 931-940
39. Yook, J. I., Li, X. Y., Ota, I., Fearon, E. R., and Weiss, S. J. (2005) Wnt-dependent regulation of the Ecadherin repressor snail. J. Biol. Chem. 280, 11740-11748
40. Lin, S., Shen, H., Li, J. L., Tang, S., Gu, Y., Chen, Z., Hu, C., Rice, J. C., Lu, J., and Wu, L. (2013) Proteomic and functional analyses reveal the role of chromatin reader SFMBT1 in regulating epigenetic silencing and the myogenic gene program. J. Biol. Chem. 288, 6238-6247
41. De Frutos, C. A., Dacquin, R., Vega, S., Jurdic, P., Machuca-Gayet, I., and Nieto, M. A. (2009) Snail1 controls bone mass by regulating Runx2 and VDR expression during osteoblast differentiation. EMBO J. 28, 686-696
42. Barski, A., Cuddapah, S., Cui, K., Roh, T. Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., and Zhao, K. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837
43. Xu, J., Lamouille, S., and Derynck, R. (2009) TGF-α-induced epithelial to mesenchymal transition. Cell Res. 19, 156-172
44. Vincent, T., Neve, E. P., Johnson, J. R., Kukalev, A., Rojo, F., Albanell, J., Pietras, K., Virtanen, I., Philipson, L., Leopold, P. L., Crystal, R. G., De Herreros, A. G., Moustakas, A., Pettersson, R. F., and Fuxe, J. (2009) A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-α mediated epithelial-mesenchymal transition. Nat. Cell Biol. 11, 943-950
45. Liu, Y.-N., Abou-Kheir, W., Yin, J. J., Fang, L., Hynes, P., Casey, O., Hu, D., Wan, Y., Seng, V., Sheppard-Tillman, H., Martin, P., and Kelly, K. (2012) Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor α-initiated prostate cancer epithelial-mesenchymal transition. Mol. Cell. Biol. 32, 941-953
46. Batlle, R., Alba-Castellón, L., Loubat-Casanovas, J., Armenteros, E., Francí, C., Stanisavljevic, J., Banderas, R., Martin-Caballero, J., Bonilla, F., Baulida, J., Casal, J. I., Gridley, T., and De Herreros, A. G. (2013) Snail1 controls TGF-α responsiveness and differentiation of mesenchymal stem cells. Oncogene 32, 3381-3389
47. Chervona, Y., and Costa, M. (2012) The control of histone methylation and gene expression by oxidative stress, hypoxia, and metals. Free Radic. Biol. Med. 53, 1041-1047
48. Wu, C. H., Tang, S. C., Wang, P. H., Lee, H., and Ko, J. L. (2012) nickelinduced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation. J. Biol. Chem. 287, 25292-25302
49. Hatzis, C., Pusztai, L., Valero, V., Booser, D. J., Esserman, L., Lluch, A., Vidaurre, T., Holmes, F., Souchon, E., Wang, H., Martin, M., Cotrina, J., Gomez, H., Hubbard, R., Chacón, J. I., Ferrer-Lozano, J., Dyer, R., Buxton, M., Gong, Y., Wu, Y., Ibrahim, N., Andreopoulou, E., Ueno, N. T., Hunt, K., Yang, W., Nazario, A., DeMichele, A., O'Shaughnessy, J., Hortobagyi, G. N., and Symmans, W. F. (2011) A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305, 1873-1881
50. Zhang, J., Bonasio, R., Strino, F., Kluger, Y., Holloway, J. K., Modzelewski, A. J., Cohen, P. E., and Reinberg, D. (2013) SFMBT1 functions with LSD1 to regulate expression of canonical histone genes and chromatin-related factors. Genes Dev. 27, 749-766
51. Lan, F., Collins, R. E., De Cegli, R., Alpatov, R., Horton, J. R., Shi, X., Gozani, O., Cheng, X., and Shi, Y. (2007) Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature 448, 718-722
52. Koester-Eiserfunke, N., and Fischle, W. (2011). H3K9me2/3 binding of the MBT domain protein LIN-61 is essential for Caenorhabditis elegans vulva development. PLoS Genet. 7, e1002017
53. Dawson, M. A., Kouzarides, T., and Huntly, B. J. (2012) Targeting epigenetic readers in cancer. N. Engl. J. Med. 367, 647-657
54. Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., and Schapira, M. (2012) Epigenetic protein families. A new frontier for drug discovery. Nat. Rev. Drug Discov. 11, 384-400
55. James, L. I., Barsyte-Lovejoy, D., Zhong, N., Krichevsky, L., Korboukh, V. K., Herold, J. M., MacNevin, C. J., Norris, J. L., Sagum, C. A., Tempel, W., Marcon, E., Guo, H., Gao, C., Huang, X. P., Duan, S., Emili, A., Greenblatt, J. F., Kireev, D. B., Jin, J., Janzen, W. P., Brown, P. J., Bedford, M. T., Arrowsmith, C. H., and Frye, S. V. (2013) Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain. Nat. Chem. Biol. 9, 184-191
56. Huang, Y., Greene, E., Murray Stewart, T., Goodwin, A. C., Baylin, S. B., Woster, P. M., and Casero, R. A., Jr. (2007) Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc. Natl. Acad. Sci. U. S. A. 104, 8023-8028